CompuMed, Inc. is a leading provider of diagnostic telemedicine solutions, specializing in telecardiology and teleradiology services. The company offers real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices, aiming to deliver high-quality clinical care efficiently and cost-effectively. With over 30 years in operation, CompuMed serves more than 1,000 clinical settings, including hospitals, occupational health clinics, urgent care centers, surgical centers, organ procurement organizations, rural clinics, correctional facilities, and various branches of the U.S. Federal and State Government.
Key Strategic Focus
CompuMed's strategic focus centers on enhancing diagnostic accuracy and accessibility through telemedicine. The company specializes in telecardiology and teleradiology, utilizing advanced cloud-based platforms and integrated medical devices to provide timely diagnostic interpretations. By offering on-demand access to expert physician specialists, CompuMed aims to improve patient outcomes and streamline healthcare delivery across diverse medical settings.
Financials and Funding
As of December 17, 2024, CompuMed reported a market capitalization of approximately $5.21 million, with revenues totaling $1.69 million over the trailing twelve months. The company experienced a net loss of $146,000 during this period. CompuMed has 1.32 million shares outstanding, with a current stock price of $3.94.
Pipeline Development
CompuMed continues to expand its diagnostic telemedicine services, focusing on integrating advanced technologies to enhance service offerings. Recent collaborations, such as the partnership with Techcyte to integrate digital pathology reviewing platforms, aim to improve diagnostic accuracy and efficiency, particularly in organ transplantation processes.
Technological Platform and Innovation
CompuMed leverages a robust telemedicine infrastructure that includes:
- Proprietary Technologies: The company developed one of the industry's first interpretive electrocardiogram (ECG) algorithms, providing rapid and accurate ECG analyses.
- Scientific Methodologies: Utilizing cloud-based platforms, CompuMed ensures secure and efficient transmission of diagnostic data, facilitating real-time consultations and interpretations by board-certified specialists.
Leadership Team
CompuMed's leadership comprises experienced professionals dedicated to advancing telemedicine solutions:
- Lee Keddie: President and Chief Executive Officer, overseeing strategic direction and operations.
- L. C.: Chief Operating Officer, responsible for managing daily operations and implementing business strategies.
- L. J. C.: Chief Financial Officer & Secretary, handling financial planning and corporate governance.
Leadership Changes
In June 2023, CompuMed announced the purchase of shares held by V.I. Capital Fund, leading to the resignation of Mr. Pointer from his position as Chairman and Director.
Competitor Profile
Market Insights and Dynamics: The telemedicine industry is experiencing significant growth, driven by the increasing demand for remote healthcare services and advancements in digital health technologies.
Competitor Analysis: Key competitors in the diagnostic telemedicine space include:
- Carepatron: Offers a healthcare workspace for managing clients, appointments, and payments.
- Tebra (formerly Kareo + PatientPop): Provides cloud-based solutions for medical practice management.
- WebPT: Specializes in electronic medical records for physical therapists.
- ClinicMind: Delivers workflow components for mental health practice management.
- Rectangle Health: Enhances practice management with financial and administrative solutions.
Strategic Collaborations and Partnerships
CompuMed has engaged in strategic partnerships to enhance its service offerings:
- Techcyte Collaboration: Integrated Techcyte's digital pathology reviewing platform to improve diagnostic processes in organ transplantation.
- FireStarter Partnership: Collaborated with FireStarter to advance organ donation and transplantation efforts through innovative marketing strategies.
Operational Insights
CompuMed's strategic considerations include:
- Market Position: Maintaining a competitive edge through continuous technological innovation and service expansion.
- Competitive Advantages: Offering a comprehensive suite of telemedicine services with a focus on diagnostic accuracy and timely delivery.
Strategic Opportunities and Future Directions
CompuMed aims to:
- Expand Service Offerings: Develop new telemedicine solutions to address emerging healthcare needs.
- Enhance Technological Capabilities: Invest in advanced technologies to improve diagnostic accuracy and efficiency.
- Strengthen Market Presence: Pursue strategic partnerships and collaborations to broaden service reach and impact.
Contact Information
- Website: compumedinc.com
- LinkedIn: CompuMed, Inc.
- Headquarters: Los Angeles, CA, USA
